Kate Addison
About Kate Addison
Kate Addison is a Scientist II specializing in T Cell Cloning at Adaptimmune US, where she has worked since 2016. She has previous experience as an event promoter at Kreate and as a drug safety scientist at Johnson & Johnson.
Current Role at Adaptimmune
Kate Addison currently serves as a Scientist II specializing in T Cell Cloning at Adaptimmune US. She has held this position since 2016, contributing to the development of innovative therapies in the field of immunotherapy. Her role involves advanced techniques in T cell engineering and cloning, which are essential for creating effective treatments for various diseases.
Previous Experience in Drug Safety
Before joining Adaptimmune, Kate Addison worked at Johnson & Johnson as a Drug Safety Scientist from 2009 to 2010. In this role, she focused on ensuring the safety and efficacy of pharmaceutical products. Her experience in drug safety provided her with a strong foundation in regulatory compliance and risk assessment within the pharmaceutical industry.
Event Promotion Experience
From 2007 to 2009, Kate Addison worked as an Event Promoter at Kreate. During her two years in this role, she was responsible for organizing and promoting various events. This experience helped her develop skills in communication, marketing, and project management, which are valuable in her current scientific career.
Educational Background at Cardiff University
Kate Addison studied at Cardiff University (Prifysgol Caerdydd) from 2007 to 2012, completing a five-year program. Her education provided her with a solid grounding in the biological sciences, which has been instrumental in her subsequent roles in the pharmaceutical and biotechnology sectors.